> it's a lack of urgency from the government and private sector to make sure a medically critical product is available.

Yes and no. But mostly no. It's that we're optimized for the best case scenario. We're in love with theory, of economies of scale and a world with no pot holes (so to speak).

That's profitable. But it's also ridiculous and stupid.

If Abbot being compromised can lead to this then that smells like a monopoly. Or at least a bad case of cronie capitalism. Three companies is not a rant. It's The Root Problem.